Statistical analyses revealed that levels of GABRA3 protein correlated significantly with TNM clinical stage (P < 0.001), lymph node metastasis status (P < 0.001) and patient survival (P = 0.042; Supplementary Table 2). Here, GABRA3 is linked to metastatic malignant neoplasm in the lymph nodes.